Portage Biotech Inc Ord (NQ: PRTG )
3.650 UNCHANGED Streaming Delayed Price Updated: 3:59 PM EDT, Jun 2, 2023 Add to My Watchlist
Headline News about Portage Biotech Inc Ord
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 07, 2022
HC Wainwright & Co. Maintains Buy Rating for Portage Biotech: Here's What You Need To Know
September 20, 2022
HC Wainwright & Co. has decided to maintain its Buy rating of Portage Biotech (NASDAQ:PRTG) and lower its price target from $32.00 to $22.00. Shares of Portage Biotech are trading down 3.11% over the...
Portage Biotech Shares Encouraging Preliminary Safety Data From Lead iNKT Agonists Program In Cancer Patients
March 31, 2022
Portage Biotech Inc (NASDAQ: PRTG) has updated its clinical development programs and announced its development goals for 2022, and it continues to work toward multiple clinical readouts in 2022.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following